Therefore, 2–4 × 106 CD34+ cells/kg body weight were recently defined as minimum and 8–10 × 106 CD34+ cells/kg bw as optimum dose for autologous (tandem) transplantation in patients with multiple myeloma (MM) [23]. Here, CD34 is linked to Miyoshi myopathy.